Literature DB >> 24499274

Biology of CD1- and MR1-restricted T cells.

Mariolina Salio1, Jonathan D Silk, E Yvonne Jones, Vincenzo Cerundolo.   

Abstract

Over the past 15 years, investigators have shown that T lymphocytes can recognize not only peptides in the context of MHC class I and class II molecules but also foreign and self-lipids in association with the nonclassical MHC class I-like molecules, CD1 proteins. In this review, we describe the most recent events in the field, with particular emphasis on (a) structural and functional aspects of lipid presentation by CD1 molecules, (b) the development of CD1d-restricted invariant natural killer T (iNKT) cells and transcription factors required for their differentiation, (c) the ability of iNKT cells to modulate innate and adaptive immune responses through their cross talk with lymphoid and myeloid cells, and (d) MR1-restricted and group I (CD1a, CD1b, and CD1c)-restricted T cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24499274     DOI: 10.1146/annurev-immunol-032713-120243

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  124 in total

1.  Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.

Authors:  Xingguang Liu; Peng Zhang; Yunkai Zhang; Zheng Wang; Sheng Xu; Yingke Li; Wanwan Huai; Qingqing Zhou; Xiang Chen; Xi Chen; Nan Li; Peng Wang; Yunsen Li; Xuetao Cao
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

2.  Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial.

Authors:  Mark A Exley; Phillip Friedlander; Nadia Alatrakchi; Lianne Vriend; Simon Yue; Tetsuro Sasada; Wanyong Zeng; Yo Mizukami; Justice Clark; David Nemer; Kenneth LeClair; Christine Canning; Heather Daley; Glenn Dranoff; Anita Giobbie-Hurder; F Stephen Hodi; Jerome Ritz; Steven P Balk
Journal:  Clin Cancer Res       Date:  2017-02-13       Impact factor: 12.531

Review 3.  Stages versus subsets: Invariant Natural Killer T cell lineage differentiation.

Authors:  Heather M Buechel; Martin H Stradner; Louise M D'Cruz
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

4.  Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision.

Authors:  Jun Wei; Kai Yang; Hongbo Chi
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

5.  Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.

Authors:  Andrew N Keller; Sidonia B G Eckle; Weijun Xu; Ligong Liu; Victoria A Hughes; Jeffrey Y W Mak; Bronwyn S Meehan; Troi Pediongco; Richard W Birkinshaw; Zhenjun Chen; Huimeng Wang; Criselle D'Souza; Lars Kjer-Nielsen; Nicholas A Gherardin; Dale I Godfrey; Lyudmila Kostenko; Alexandra J Corbett; Anthony W Purcell; David P Fairlie; James McCluskey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2017-02-06       Impact factor: 25.606

Review 6.  The interaction between invariant Natural Killer T cells and the mucosal microbiota.

Authors:  Fatma Zehra Hapil; Gerhard Wingender
Journal:  Immunology       Date:  2018-07-11       Impact factor: 7.397

Review 7.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

8.  Molecular Analysis of Lipid-Reactive Vδ1 γδ T Cells Identified by CD1c Tetramers.

Authors:  Sobhan Roy; Dalam Ly; Caitlin D Castro; Nan-Sheng Li; Andrew J Hawk; John D Altman; Stephen C Meredith; Joseph A Piccirilli; D Branch Moody; Erin J Adams
Journal:  J Immunol       Date:  2016-01-11       Impact factor: 5.422

Review 9.  Mechanisms and Consequences of Antigen Presentation by CD1.

Authors:  Luc Van Kaer; Lan Wu; Sebastian Joyce
Journal:  Trends Immunol       Date:  2016-09-09       Impact factor: 16.687

Review 10.  mTOR and its tight regulation for iNKT cell development and effector function.

Authors:  Wei Yang; Balachandra Gorentla; Xiao-Ping Zhong; Jinwook Shin
Journal:  Mol Immunol       Date:  2015-08-04       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.